Results 51 to 60 of about 21,026 (236)
BMC Cardiovascular Disorders, 2022 Background Hypertrophic cardiomyopathy with extreme hypertrophy, biventricular obstruction and diffuse myocardial fibrosis complicated by myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) is a rare phenotype.
Yunhong Wang +7 more
doaj +1 more source
Extended myectomy for hypertrophic obstructive cardiomyopathy [PDF]
The Annals of Thoracic Surgery, 1994 An extended surgical technique for better relief of the obstruction as well as of mitral valve incompetence in patients with hypertrophic obstructive cardiomyopathy is presented. In addition to the traditional septal myectomy facilitated by insertion of a sharp triple-hook retractor, operation is extended to the hypertrophied and mal-attached papillary
openaire +4 more sources
Alcohol septal ablation: patient selection and rationality of its application
Патология кровообращения и кардиохирургия, 2017 The article looks at some aspects of selecting patients with obstructive hypertrophic cardiomyopathy for alcohol septal ablation (ASA) procedure. Based on the world’s experience and in the context of evidence-based medicine, the current positions of ASA ...
М. Г. Каштанов +4 more
doaj +1 more source
HeartBEiT: Vision Transformer for Electrocardiogram Data Improves Diagnostic Performance at Low Sample Sizes [PDF]
arXiv, 2022 The electrocardiogram (ECG) is a ubiquitous diagnostic modality. Convolutional neural networks (CNNs) applied towards ECG analysis require large sample sizes, and transfer learning approaches result in suboptimal performance when pre-training is done on natural images.
arxiv
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy [PDF]
New England Journal of MedicineOne of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from left ventricular outflow tract obstruction. Aficamten is an oral selective cardiac myosin inhibitor that reduces left ventricular outflow tract gradients by ...
Maron, Martin S +32 more
openaire +4 more sources
Mavacamten for hypertrophic obstructive cardiomyopathy [PDF]
The Lancet, 2021 Patrick Olivier Myers +2 more
openaire +3 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Patients with obstructive hypertrophic cardiomyopathy have increased symptomatic burden. Mavacamten was recently approved for treatment of obstructive hypertrophic cardiomyopathy based on 2 randomized controlled trials.
Diego Ramonfaur +9 more
doaj +1 more source
The case for surgery in obstructive hypertrophic cardiomyopathy
Journal of the American College of Cardiology, 2004 Relief of left ventricular (LV) outflow obstruction in patients with hypertrophic cardiomyopathy (HCM) and disabling symptoms refractory to maximum medical management has historically been a surgical problem. Surgical septal myectomy permanently abolishes systolic anterior motion of the mitral valve and mitral regurgitation, while normalizing LV ...
Martin S. Maron +6 more
openaire +3 more sources
Journal of Chest Surgery, 2022 Surgical septal myectomy is the preferred treatment option for patients with medically intractable obstructive hypertrophic cardiomyopathy. Extended transaortic septal myectomy is a widely performed surgical procedure for patients with subaortic ...
Dong Youb Han +2 more
doaj +1 more source
Segmentation of the Myocardium on Late-Gadolinium Enhanced MRI based on 2.5 D Residual Squeeze and Excitation Deep Learning Model [PDF]
arXiv, 2020 Cardiac left ventricular (LV) segmentation from short-axis MRI acquired 10 minutes after the injection of a contrast agent (LGE-MRI) is a necessary step in the processing allowing the identification and diagnosis of cardiac diseases such as myocardial infarction.
arxiv